Related references
Note: Only part of the references are listed.Current views on the genetic landscape and management of variant acute promyelocytic leukemia
Xiang Zhang et al.
BIOMARKER RESEARCH (2021)
Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene
Alessandro Liquori et al.
CANCERS (2020)
Classic and Variants APLs, as Viewed from a Therapy Response
Marie-Claude Geoffroy et al.
CANCERS (2020)
Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions
Lijun Wen et al.
HAEMATOLOGICA (2019)
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2019)
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
Dan R. Robinson et al.
NATURE GENETICS (2013)
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Harry J. Iland et al.
BLOOD (2012)
NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex
Rajini Srinivasan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)